The PINK Kilishee Token

Kilishee sdg-04

SDG 3 – Facilitating a campaign to end Cancer while boosting opportunities for Universal Healthcare Coverage.

The Pink KILISHI Token, aligned with SDG 3 – Ensuring healthy lives and promoting well-being for all at all ages, holds immense importance as it addresses critical health challenges, particularly cancer, and supports efforts to achieve universal healthcare coverage. The significance lies in its potential to drive awareness, funding and action towards ending cancer while simultaneously advancing the goal of accessible and equitable healthcare for all.

The impact investments generated by the token serve as a catalyst for raising awareness about cancer prevention, detection and treatment. By facilitating campaigns and initiatives focused on ending cancer, the Pink KILISHI Token educates individuals and communities about risk factors, early warning signs, and available resources for cancer care. This awareness-building effort is essential for empowering individuals to take proactive steps towards prevention and early intervention, thereby reducing the burden of cancer and improving health outcomes.

The Pink KILISHI Token supports efforts to boost opportunities for universal healthcare coverage by advocating for policies and programs that ensure access to essential health services for all individuals, regardless of their socio-economic status. By promoting initiatives that expand access to cancer screenings, diagnostics, treatment and palliative care, the token contributes to the realization of SDG 3 targets related to reducing premature mortality from non-communicable diseases, including cancer.

kilishi kulture SDG icon-07

$10

Mobile | 5GB Mobile Data
M-surrance | Healthcare
Mheritage Pot | Food-Diversity
M-humanity | AidAfrika
Mpepper | Choppmillionaire
Mgreen | Plant A Tree

kilishi kulture SDG icon-07

$100

Mobile | 50GB Mobile Data
M-surrance | Healthcare
Mheritage Pot | Food-Diversity
M-humanity | AidAfrika
Mpepper | Choppmillionaire
Mgreen | Plant A Tree

Comments are closed.